Keith Summa
Hospitalist · Chicago, ILNPI 1780074476
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $5,490 of the $6,837 with a category attached, or 80.3%. E.r. Squibb & Sons, L.L.C. accounts for 81.3% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2023 at $6,282 and has fallen 99.4% since, to $36 in 2025. Among hospitalist clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 22 payments — averaging $310.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$6K
- Bristol Myers Squibb$811
- Janssen Scientific Affairs, LLC$147
- Johnson & Johnson$127
- Celltrion USA Inc.$66
- AbbVie$45
- plus $84 from 3 others
Across 1 payment — averaging $17,556 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$18K
What the payments were for
- Consulting fees$5,49080%
- Travel & lodging$65810%
- Food & beverage$5899%
- Education$991%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 3 | $5,556 |
| Bristol Myers Squibb | 8 | $811 |
| Janssen Scientific Affairs, LLC | 2 | $147 |
| Johnson & Johnson | 2 | $127 |
| Celltrion USA Inc. | 1 | $66 |
| AbbVie | 2 | $45 |
| Mauna Kea Technologies, Inc. | 1 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,837 in reported general payments places this provider in the 95th percentile of 1,328 hospitalist providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mesalamine | 11 | $7,053 |
| Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg | 22 | $460 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Chicago
- Salih SamoChicago$251K
- Eric GluckChicago$80K
- Alvin ThomasChicago$28K
- Tasmeen HussainChicago$18K
- Ronnie MandalChicago$10K
- Bobby DiniotisChicago$9K
- Nael GharbiChicago$8K
- Alicia RauhChicago$6K
- Anish MunagalaChicago$5K
- Jorge ChedrauyChicago$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.